Inanta Competitors

Started in 2000 and having served over ten million patients during our tenure, MedDirect is a patient services company owned by MedData, Inc. MedDirect provides comprehensive outsourced patient billing and communication solutions to leading healthcare providers, connecting with patients immediately after care through personalized, multi-channel communications. Our technology and services seamlessly integrate with a provider’s existing billing platform so there is no need to disrupt current insurance billing processes. As a result, the implementation process requires minimal involvement of your I.T. staff and is provided at our expense. We offer the program as an “Extended Business Office” solution that connects with patients who are uninsured or have balances after insurance adjudication via customized communications prior to receiving their first bill. We do this via proven patient segmentation and outreach strategies that educate, engage and communicate with patients in a way that drives results. Our technology and hands-on process includes patient satisfaction services and feedback loops to both the client and their billing service/office that increases patient pay revenue, finds and updates insurance, enhances the patient's pre and post-clinical experience, streamlines operations and transforms patients into well-informed and loyal customers.

MNX is the leading provider of national and international specialty logistics services specifically tailored to the entertainment & media, medical device, life sciences, luxury fashion, secure custody & control and aviation, aerospace & MRO industries. Since the early 1970's, MNX has been regarded as specialists in this fast paced and demanding environment, offering an unparalleled mix of versatile and customized services for all your transportation and logistics needs.

Pharmatech, Inc. is a Site Management Organization (SMO) that specializes in creating efficiencies in the clinical trial process. Through an organized network of clinics, the Company focuses on advancing the development of products for a broad range of pharmaceutical and biotechnology companies, and on promoting the inclusion of clinical trials in the spectrum of patient treatment options.